Table 1.
Bivariate Comparisons of Patients Living with HIV/HCV Co-infection with and without Antiretroviral (ART) Adherence
| Variables | Sample | ART Adherence | ART Non-Adherence | Significance |
|---|---|---|---|---|
| N | 137 (100%) | 95 (69%) | 42 (31%) | P-value |
| Demographics | ||||
| Sex | 0.299 | |||
| Male | 103(75%) | 69 (73%) | 34 (81%) | |
| Female | 34 (25%) | 26 (27%) | 8 (19%) | |
| Age | 55.59 (10.09) | 56.71 (9.85) | 53.00 (9.02) | 0.039* |
| Ethnicity | 0.035* | |||
| Non-African American | 54 (39%) | 43 (45%) | 11 (26%) | |
| African American | 83 (61%) | 52 (55%) | 31 (74%) | |
| Insurance Status | 0.582 | |||
| Private | 34 (25%) | 26 (27%) | 8 (19%) | |
| Public | 76 (56%) | 51 (54%) | 25 (60%) | |
| Uninsured | 27 (20%) | 18 (19%) | 9 (21%) | |
| Medical Conditions | ||||
| Medical Conditions in
Addition HIV/HCV Co-infection |
64 (47%) | 46 (48%) | 18 (43%) | 0.547 |
| HCV Characteristics | ||||
| Genotype 1 | 39 (91%) | 30 (88%) | 9 (100%) | 0.564 |
| Cirrhosis | 31 (23%) | 25 (26%) | 6 (14%) | 0.121 |
| Psychiatric Disorders | ||||
| Psychiatric Disorder | 66 (63%) | 46 (66%) | 20 (57%) | 0.392 |
| Alcohol Use | ||||
| Alcohol Use Disorder | 34 (32%) | 20 (29%) | 14 (40%) | 0.238 |
| Current Alcohol Use | 78 (66%) | 46 (58%) | 32 (82%) | 0.010* |
| Number of Alcoholic Drinks per Drinking Day | 1.85 (1.98) | 1.54 (1.88) | 2.38 (2.03) | 0.028* |
| Tobacco Use | ||||
| Current Tobacco Use | 80 (59%) | 54 (57%) | 26 (65%) | 0.378 |
| Substance Use | ||||
| Substance Use Disorder | 79 (75%) | 50 (71%) | 29 (83%) | 0.201 |
| Lifetime Illicit Substance Use | 116 (87%) | 78 (85%) | 38 (91%) | 0.370 |
| Current Illicit Substance Use | 40 (30%) | 27 (29%) | 13 (31%) | 0.851 |
| Substance Use Treatment | ||||
| Ever Received Treatment for Substance Use | 42 (32%) | 29 (32%) | 13 (32%) | 0.985 |
| Health-Related Quality of Life | ||||
| EQ Index (Health-Related Quality of
Life) Score |
0.76 (0.18) | 0.81 (0.17) | 0.74 (0.18) | 0.07 |
*
P < 0.05